An <sup>18</sup> F-labeled ECL1i-Based C–C Chemokine Receptor Type 2 Radiotracer for Cardiac Inflammation Imaging

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2026-05-18
DOI
https://doi.org/10.1021/acs.molpharmaceut.6c00266
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An 18 F-labeled ECL1i-Based C–C Chemokine Receptor Type 2 Radiotracer for Cardiac Inflammation Imaging

Wanjie Ren, Ding Ding, S Song, Min Ju et al.
Molecular Pharmaceutics
Cardiac Fibrosis and Remodeling
article

An 18 F-labeled ECL1i-Based C–C Chemokine Receptor Type 2 Radiotracer for Cardiac Inflammation Imaging

Wanjie Ren, Ding Ding, S Song, Min Ju, Wei Fang, Yue Zhou, Yufan Gu, Ke Wang, Ruoxi Sun, Lei Wang
article en

Abstract

No abstract available for this paper.
Molecular Pharmaceutics
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fu Wai Hospital (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 6%
Cardiac Fibrosis and Remodeling
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.